Eton Pharmaceuticals (ETON) Cash from Operations (2018 - 2025)

Eton Pharmaceuticals has disclosed Cash from Operations across 8 years of filings, most recently posting -$11.6 million for Q4 2025.

• In Q4 2025, Cash from Operations fell 1409.93% year-over-year to -$11.6 million; the TTM figure through Dec 2025 stood at $10.5 million (up 986.07% YoY), while the FY2025 annual figure was $10.5 million, up 986.07% from the prior year.
• Cash from Operations came in at -$11.6 million for Q4 2025 at Eton Pharmaceuticals, down from $12.0 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $12.0 million in Q3 2025 to a low of -$11.6 million in Q4 2025.
• Average Cash from Operations over 5 years is $920400.0, with a median of $1.0 million recorded in 2022.
• Year-over-year, Cash from Operations jumped 766.94% in 2022 and plunged 1409.93% in 2025.
• Over 5 years, Cash from Operations stood at -$5.1 million in 2021, then jumped by 155.5% to $2.8 million in 2022, then sank by 86.37% to $387000.0 in 2023, then sank by 297.67% to -$765000.0 in 2024, then sank by 1409.93% to -$11.6 million in 2025.
• Per Business Quant data, the three most recent Cash from Operations figures were -$11.6 million in Q4 2025, $12.0 million in Q3 2025, and $8.0 million in Q2 2025.